Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mebendazole | 1 | 2018 | 6 | 0.76 | Why? |
| Intestinal Diseases, Parasitic | 1 | 2017 | 34 | 0.69 | Why? |
| Anthelmintics | 1 | 2018 | 104 | 0.67 | Why? |
| Helminthiasis | 1 | 2018 | 78 | 0.67 | Why? |
| Strongyloides stercoralis | 1 | 2017 | 70 | 0.65 | Why? |
| Strongyloidiasis | 1 | 2017 | 80 | 0.63 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.60 | Why? |
| Immune System Diseases | 1 | 2018 | 410 | 0.52 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.52 | Why? |
| Bolivia | 5 | 2018 | 187 | 0.48 | Why? |
| Rural Population | 5 | 2018 | 2408 | 0.47 | Why? |
| Antimicrobial Stewardship | 1 | 2020 | 931 | 0.47 | Why? |
| Hepatitis B, Chronic | 1 | 2018 | 616 | 0.44 | Why? |
| Hepatitis B virus | 1 | 2018 | 882 | 0.43 | Why? |
| Rituximab | 1 | 2018 | 1096 | 0.41 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.37 | Why? |
| Dengue | 1 | 2020 | 1565 | 0.34 | Why? |
| Soil | 2 | 2018 | 137 | 0.33 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.23 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.22 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.19 | Why? |
| Splenic Diseases | 1 | 2019 | 28 | 0.19 | Why? |
| Cytotoxicity, Immunologic | 1 | 2020 | 287 | 0.18 | Why? |
| Leishmaniasis, Visceral | 1 | 2019 | 85 | 0.18 | Why? |
| Trypanosoma cruzi | 1 | 2018 | 133 | 0.17 | Why? |
| Hepatitis A virus | 1 | 2018 | 68 | 0.17 | Why? |
| Carrier State | 2 | 2020 | 2100 | 0.17 | Why? |
| Hepatitis B Antibodies | 1 | 2018 | 142 | 0.17 | Why? |
| Myeloproliferative Disorders | 1 | 2021 | 507 | 0.16 | Why? |
| Chagas Disease | 1 | 2018 | 155 | 0.16 | Why? |
| Hepatitis B Surface Antigens | 1 | 2018 | 305 | 0.16 | Why? |
| Interleukin-2 | 1 | 2018 | 443 | 0.16 | Why? |
| Tuberculin Test | 1 | 2017 | 141 | 0.15 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.15 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.15 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.15 | Why? |
| Helicobacter pylori | 1 | 2018 | 262 | 0.14 | Why? |
| Enterobacteriaceae | 1 | 2018 | 395 | 0.14 | Why? |
| Spleen | 1 | 2019 | 877 | 0.14 | Why? |
| Interferon-gamma Release Tests | 1 | 2017 | 253 | 0.14 | Why? |
| Remission Induction | 1 | 2018 | 950 | 0.14 | Why? |
| Hepatitis E virus | 1 | 2018 | 306 | 0.14 | Why? |
| Neglected Diseases | 1 | 2019 | 381 | 0.13 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.13 | Why? |
| Latent Tuberculosis | 1 | 2018 | 324 | 0.13 | Why? |
| Chemoprevention | 1 | 2018 | 585 | 0.13 | Why? |
| Dengue Virus | 1 | 2020 | 910 | 0.12 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.12 | Why? |
| Dog Diseases | 1 | 2018 | 745 | 0.12 | Why? |
| Seroepidemiologic Studies | 2 | 2018 | 10017 | 0.11 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.11 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.11 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.11 | Why? |
| Pyrazoles | 1 | 2021 | 1791 | 0.11 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.10 | Why? |
| Program Evaluation | 1 | 2018 | 1929 | 0.10 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.09 | Why? |
| Antimalarials | 1 | 2021 | 2505 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.09 | Why? |
| DNA, Viral | 1 | 2018 | 2521 | 0.09 | Why? |
| Prevalence | 3 | 2018 | 25773 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Male | 16 | 2021 | 367725 | 0.08 | Why? |
| Female | 16 | 2021 | 380317 | 0.08 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.08 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Aged | 11 | 2021 | 215776 | 0.07 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.07 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.07 | Why? |
| Italy | 5 | 2021 | 38444 | 0.07 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Humans | 21 | 2021 | 930598 | 0.06 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.06 | Why? |
| Child | 4 | 2018 | 70012 | 0.06 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.06 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.05 | Why? |
| Granzymes | 1 | 2020 | 197 | 0.05 | Why? |
| Respiratory Care Units | 1 | 2020 | 111 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.05 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
| Infant | 2 | 2018 | 30274 | 0.04 | Why? |
| Escherichia coli Proteins | 1 | 2018 | 168 | 0.04 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| ROC Curve | 2 | 2020 | 6024 | 0.04 | Why? |
| Animals, Domestic | 1 | 2018 | 272 | 0.04 | Why? |
| Adult | 9 | 2021 | 244371 | 0.04 | Why? |
| Child, Preschool | 2 | 2018 | 36283 | 0.04 | Why? |
| Receptors, Immunologic | 1 | 2020 | 555 | 0.04 | Why? |
| Nitriles | 1 | 2021 | 1053 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2020 | 724 | 0.04 | Why? |
| Carbapenems | 1 | 2018 | 343 | 0.04 | Why? |
| Models, Immunological | 1 | 2020 | 727 | 0.04 | Why? |
| Escherichia coli Infections | 1 | 2018 | 348 | 0.04 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.04 | Why? |
| Cannula | 1 | 2020 | 750 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Diagnosis, Differential | 2 | 2019 | 7220 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.03 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.03 | Why? |
| Pyrimidines | 1 | 2021 | 1557 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Patient Transfer | 1 | 2020 | 898 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Adolescent | 3 | 2018 | 86841 | 0.03 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.03 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.03 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.03 | Why? |
| Animals | 2 | 2018 | 78931 | 0.03 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Methylprednisolone | 1 | 2021 | 2107 | 0.03 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.02 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.02 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
Spinicci's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(151)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(267)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_